Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms CP-R1 |
Target |
Action degraders |
Mechanism CDK6 degraders(Cyclin-dependent kinase 6 degraders) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC43H50N14O6 |
InChIKeyXSQYNPNILAPKLU-UHFFFAOYSA-N |
CAS Registry2366269-05-6 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Multiple Myeloma | Preclinical | China | 22 Jul 2019 |





